PHI with Gastroduodenal ulcer
How does this condition affect your private health insurance?
A gastroduodenal ulcer, commonly known as a peptic ulcer, is an open sore that develops on the lining of the stomach (gastric ulcer) or the first part of the small intestine (duodenal ulcer). The most common causes are infection with Helicobacter pylori bacteria and long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs). Symptoms often include burning stomach pain, especially between meals or at night, bloating, heartburn, nausea, or vomiting. Left untreated, complications such as bleeding, perforation, or obstruction can occur, which are medical emergencies. Diagnosis involves endoscopy. Treatment typically includes antibiotics for H. pylori, proton pump inhibitors to reduce stomach acid, and lifestyle modifications to promote healing.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 15%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to a few months for healing with appropriate treatment; can be chronic if left untreated.
Duration of Illness (Lifetime)
Can be a one-time event with successful treatment and eradication of underlying causes; however, recurrence is possible, making it potentially chronic or recurrent.
Cost of Treatment (Initial)
Moderate to high, including diagnostic endoscopy, medications (e.g., antibiotics, PPIs), and physician visits; significantly higher if complications require hospitalization or surgery.
Cost of Treatment (Lifetime)
Can be substantial over a lifetime, especially if recurrent episodes occur or if complications arise requiring multiple interventions or long-term medication.
Mortality Rate
Low for uncomplicated ulcers; however, the probability increases significantly with severe complications like massive hemorrhage (up to 10%) or perforation (up to 20%), which are medical emergencies.
Risk of Secondary Damages
High if left untreated, including gastrointestinal bleeding (most common complication), perforation leading to peritonitis, gastric outlet obstruction due to scarring, and anemia.
Probability of Full Recovery
High with appropriate and timely treatment, especially with successful eradication of H. pylori and avoidance of NSAIDs, leading to complete mucosal healing without long-term consequences.
Underlying Disease Risk
Very high for Helicobacter pylori infection (over 80% of cases) or chronic NSAID use. Less common but possible for rare conditions like Zollinger-Ellison syndrome or other systemic illnesses.